LIFE:ATAI
atai Life Sciences
- Stock
Last Close
1.52
22/11 21:00
Market Cap
199.68M
Beta: -
Volume Today
2.09M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 315K - | 228.50K 27.46% | -2.82M - | |||
average payables | 1.89M - | 4.54M 140.97% | 4.20M 7.53% | 3.49M 16.84% | ||
average receivables | 5.00M - | 1.10M 77.95% | 456.50K 58.58% | 3.94M 763.96% | ||
book value per share | 0.39 - | 0.60 54.59% | -2.52 522.97% | 1.67 166.50% | 1.53 8.65% | |
capex per share | -0.00 - | -0.00 210.53% | -0.01 2,009.65% | -0.01 19.39% | -0.00 43.51% | |
capex to depreciation | -3.17 - | -2.46 22.37% | -24 876.27% | -6.10 74.60% | -1.85 69.66% | |
capex to operating cash flow | 0.00 - | 0.00 17.33% | 0.02 527.74% | 0.01 45.04% | 0.01 28.44% | |
capex to revenue | -0.06 - | -4.39 7,838.78% | -1.88 57.25% | |||
cash per share | 0.20 - | 0.64 223.48% | 2.62 311.06% | 1.75 33.06% | 0.97 44.63% | |
days of inventory on hand | 0.00 - | |||||
days payables outstanding | 5.25K - | |||||
days sales outstanding | 16.35 - | 2.62K - | ||||
debt to assets | 0.00 - | 0.02 672.15% | 0.00 90.81% | 0.05 2,658.82% | 0.05 6.62% | |
debt to equity | 0.00 - | 0.02 796.98% | -0.00 108.90% | 0.06 2,816.56% | 0.06 9.94% | |
dividend yield | ||||||
earnings yield | -0.06 - | -0.03 45.02% | -0.13 265.28% | -0.34 171.59% | -0.18 47.39% | |
enterprise value | 249.30M - | 2.87B 1,052.20% | 693.45M 75.86% | 238.72M 65.58% | 195.40M 18.15% | |
enterprise value over ebitda | 157.78 - | -29.17 118.49% | -6.61 77.33% | -1.66 74.95% | -1.56 5.77% | |
ev to operating cash flow | -31.77 - | -138.32 335.34% | -10.96 92.07% | -2.29 79.16% | -2.32 1.65% | |
ev to sales | 34.03 - | 1.02K 2,910.48% | 622.29 39.26% | |||
free cash flow per share | -0.05 - | -0.14 164.78% | -0.47 241.10% | -0.68 45.50% | -0.53 21.28% | |
free cash flow yield | -0.03 - | -0.01 75.09% | -0.06 769.51% | -0.25 317.37% | -0.38 48.52% | |
graham net net | 0.22 - | 0.54 140.54% | -0.30 156.56% | -0.18 42.50% | 0.67 483.41% | |
graham number | 1.00 - | 2.99 200.55% | 7.37 146.19% | 5.85 20.65% | 2.95 49.53% | |
income quality | 0.32 - | 0.12 63.87% | 0.36 212.22% | 0.66 82.83% | 2.09 215.12% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -75.61 - | 47.24 162.48% | ||||
interest debt per share | 0.00 - | 0.01 1,286.62% | 0.01 62.34% | 0.11 1,935.39% | 0.08 26.15% | |
inventory turnover | 319.00K - | |||||
invested capital | 0.00 - | 0.02 796.98% | -0.00 108.90% | 0.06 2,816.56% | 0.06 9.94% | |
market cap | 279.20M - | 2.97B 962.84% | 1.05B 64.45% | 414.21M 60.74% | 223.96M 45.93% | |
net current asset value | 36.67M - | 83.37M 127.36% | -30.03M 136.02% | -13.27M 55.82% | 136.43M 1,128.11% | |
net debt to ebitda | -18.93 - | 0.97 105.10% | 3.45 257.14% | 1.22 64.67% | 0.23 81.27% | |
net income per share | -0.11 - | -0.67 484.33% | -0.96 43.30% | -0.91 5.32% | -0.25 72.11% | |
operating cash flow per share | -0.05 - | -0.14 164.67% | -0.46 236.07% | -0.67 46.66% | -0.53 21.06% | |
payables turnover | 0.07 - | |||||
receivables turnover | 22.32 - | 0.14 - | ||||
research and ddevelopement to revenue | 2.35 - | 318.94 13,451.42% | 197.08 38.21% | |||
return on tangible assets | -0.28 - | -0.92 225.39% | -0.32 65.02% | -0.46 44.59% | -0.14 70.40% | |
revenue per share | 0.15 - | 0.00 98.98% | 0.00 32.12% | |||
roe | -0.30 - | -1.12 277.99% | 0.38 133.88% | -0.54 242.38% | -0.17 69.47% | |
roic | 0.03 - | -1.12 4,303.88% | 0.38 133.78% | -0.55 244.67% | -0.50 9.64% | |
sales general and administrative to revenue | 4.55 - | 301.93 6,533.41% | 202.49 32.93% | |||
shareholders equity per share | 0.39 - | 0.60 54.59% | -2.52 522.97% | 1.67 166.50% | 1.53 8.65% | |
stock based compensation to revenue | 3.11 - | 181.87 5,748.49% | 105.04 42.24% | |||
tangible asset value | 59.64M - | 95.37M 59.91% | 9.05M 90.51% | 5.03M 44.47% | 244.32M 4,761.04% | |
tangible book value per share | 0.39 - | 0.63 59.91% | 0.07 89.53% | 0.03 50.69% | 1.54 4,665.73% | |
working capital | 37.54M - | 87.25M 132.42% | 354.15M 305.90% | 267.25M 24.54% | 165.47M 38.08% |
All numbers in USD (except ratios and percentages)